With the discovery of new cells in humans, various cancer cells are Curable London: Human cells have been found to specifically contain secretory cells (T cells), which are capable of targeting many types of cancer, according to scientists.
An international team of scientists has jointly discovered a new security cell. Earlier, CART immunotherapy was also an important achievement in which individual treatment was recommended for any patient. It is used to treat cancer patients by taking the cells from their body and treating them with what is called immunotherapy.
But one drawback of CART immunotherapy is that it is not possible to cure all types of cancer; secondly, it is a very time-consuming and harmful side effect treatment.
Professor Andrew Sewell, an associate professor at Cardiff University in the UK, and these international experts have covered the discovery in Nature Immunology. Exploratory T cells can differentiate into cancerous and healthy cells and act as a one-year MRN.
This molecule is found in all parts of the body, but in cancer patients, it changes yearly, which can recognize and destroy the T-cell and attack it.
The good thing is that the new T cell is capable of destroying many types of boils and messengers. That way it was not possible before a single cell could cure many cancers. Successful experiments have been performed on laboratory dishes and mice. Human trials will begin shortly after stimulating experiments.
According to Professor Andrew, in just a few years, if human experiments are successful, this treatment will help save hundreds of thousands of people from cancer. On the other hand, other experts in the same field have expressed the view that this is a revolutionary step and can be helpful in the treatment of cancer.